Identification |
Name: | Benzamide,N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methyl- |
Synonyms: | (R)-N-(3-Aminopropyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide;Ispinesib; SB 715992 |
CAS: | 336113-53-2 |
Molecular Formula: | C30H33 Cl N4 O2 |
Molecular Weight: | 0 |
InChI: | InChI=1/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 381.976°C |
Boiling Point: | 707.986°C at 760 mmHg |
Density: | 1.216g/cm3 |
Refractive index: | 1.619 |
Flash Point: | 381.976°C |
Usage: | Ispinesib is the first potent, highly specific small-molecule inhibitor of KSP tested for the treatment of human disease. Anticancer agent. |
Safety Data |
|
|